Novel approaches to the treatment of type 1 diabetes.
作者信息
Bloomgarden Zachary
机构信息
Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
出版信息
J Diabetes. 2022 Nov;14(11):724-726. doi: 10.1111/1753-0407.13333. Epub 2022 Nov 7.
Abstract
摘要
相似文献
1
Novel approaches to the treatment of type 1 diabetes.1型糖尿病的新型治疗方法。
J Diabetes. 2022 Nov;14(11):724-726. doi: 10.1111/1753-0407.13333. Epub 2022 Nov 7.
2
New approaches to improve diabetes control.改善糖尿病控制的新方法。
Am Fam Physician. 1991 Feb;43(2):570-8.
3
Diabetes mellitus in adults.成人糖尿病
Compr Ther. 1988 Sep;14(9):55-64.
4
Diabetes mellitus: implications for nursing care.糖尿病：对护理的影响。
Br J Nurs. 1994;3(9):442-5. doi: 10.12968/bjon.1994.3.9.442.
5
Management of diabetes.糖尿病的管理
J Assoc Physicians India. 1983 Apr;31(4):235-40.
6
Clinical review 51: Implications of the Diabetes Control and Complications Trial.临床综述51：糖尿病控制与并发症试验的启示
J Clin Endocrinol Metab. 1993 Nov;77(5):1105-7. doi: 10.1210/jcem.77.5.8077299.
7
Inpatient management of adults with diabetes.成人糖尿病患者的住院治疗管理
Diabetes Care. 1995 Jun;18(6):870-8. doi: 10.2337/diacare.18.6.870.
8
Advances in diabetes thinking: a critical summary and analysis of keystone 2009.糖尿病观念的进展：对2009年关键会议的批判性总结与分析
Diabetes Technol Ther. 2010 Feb;12(2):167-71. doi: 10.1089/dia.2009.0139.
9
Practical guidelines on the use of insulin lispro in elderly diabetic patients.老年糖尿病患者使用赖脯胰岛素的实用指南。
Drugs Aging. 1998 Feb;12(2):103-13. doi: 10.2165/00002512-199812020-00003.
10
Insulin Therapy: The Old, the New and the Novel-An Overview.胰岛素治疗：旧法、新法与创新疗法——综述
Nurs Clin North Am. 2017 Dec;52(4):539-552. doi: 10.1016/j.cnur.2017.07.004. Epub 2017 Oct 5.
引用本文的文献
1
Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis.基于纳米颗粒和微粒的增强口服胰岛素递送系统：系统评价与荟萃分析
J Nanobiotechnology. 2024 Dec 29;22(1):802. doi: 10.1186/s12951-024-03045-8.
2
Can type 1 diabetes be prevented or reversed?1型糖尿病可以预防或逆转吗？
J Diabetes. 2024 May;16(5):e13572. doi: 10.1111/1753-0407.13572.
3
The potential of β-cell growth promotion, continued.促进β细胞生长的潜力，续。
J Diabetes. 2023 May;15(5):366-367. doi: 10.1111/1753-0407.13396. Epub 2023 Apr 27.
本文引用的文献
1
Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice.1 型糖尿病易感和抗性小鼠胰岛素反应性 B 细胞库的比较分析。
Front Immunol. 2022 Oct 4;13:961209. doi: 10.3389/fimmu.2022.961209. eCollection 2022.
2
Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening.进展可能性评分可识别儿童公共卫生筛查中无症状 1 型糖尿病的亚临床阶段。
Diabetologia. 2022 Dec;65(12):2121-2131. doi: 10.1007/s00125-022-05780-9. Epub 2022 Aug 27.
3
A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes.R 型维拉帕米添加到正在进行的二甲双胍治疗的 2 型糖尿病患者中的一项随机对照试验。
J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4063-e4071. doi: 10.1210/clinem/dgac436.
4
Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor.设计、合成及小分子胰高血糖素样肽-1 受体口服激动剂的生物学评价。
J Biol Chem. 2022 May;298(5):101889. doi: 10.1016/j.jbc.2022.101889. Epub 2022 Apr 2.
5
Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes.探索性研究揭示了维拉帕米治疗 1 型糖尿病患者的深远的系统性和细胞性作用。
Nat Commun. 2022 Mar 3;13(1):1159. doi: 10.1038/s41467-022-28826-3.
6
Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells.糖尿病的治疗策略：胰腺β细胞的免疫调节。
Front Endocrinol (Lausanne). 2021 Aug 17;12:716692. doi: 10.3389/fendo.2021.716692. eCollection 2021.
7
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges.人胰岛β细胞再生药物治疗糖尿病：过去的成就与未来的挑战。
Front Endocrinol (Lausanne). 2021 Jul 16;12:671946. doi: 10.3389/fendo.2021.671946. eCollection 2021.
8
DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes.DYRK1A 抑制剂作为糖尿病β细胞再生的潜在治疗方法。
J Med Chem. 2021 Mar 25;64(6):2901-2922. doi: 10.1021/acs.jmedchem.0c02050. Epub 2021 Mar 8.
9
T cell Tolerance in Early Life.T 细胞在生命早期的耐受。
Front Immunol. 2020 Nov 20;11:576261. doi: 10.3389/fimmu.2020.576261. eCollection 2020.
10
Progress in Translational Regulatory T Cell Therapies for Type 1 Diabetes and Islet Transplantation.1型糖尿病和胰岛移植的转化性调节性T细胞疗法进展
Endocr Rev. 2021 Mar 15;42(2):198-218. doi: 10.1210/endrev/bnaa028.
Zotero 插件